Executive Leadership Perspectives on MA Strategic Planning - episode 1

09/11/20 • 11 min

Elevate Medical Affairs Podcast Channel

Previous Episode

The application of Real World Evidence in Regulatory Decision Making

Cerise James, MD, moderates this podcast presentation by the MAPS Evidence Generation Focus Area Working Group in which Neil Belson, JD, discusses Real World Evidence and its impact. The podcast objectives are: To define Real World Evidence, and to demonstrate RWE and its impact to Biotech/Pharma.
Mr. Belson will address a variety of topics including: The significance of Real World Evidence for the pharmaceutical and medical device industry; and, how the FDA views Real World Evidence.
This is the first podcast in a series.

Next Episode

Medical Affairs Plans: from Strategic Planning to Measuring Impact - episode 1

The Series Podcast Objectives are:

Understand how the medical affairs strategic planning process can drive decision making throughout the year
Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed
Obtain a working knowledge of how cross-functional teams within medical affairs can reference strategic plans to inform decision making and assess impact of efforts

Monica DeAbadal, MD, MBA/HSA, Vice President, Medical Excellence at Ipsen and MAPS Medical Strategy & Launch Excellence co-lead, culled out highlights from the Medical Strategy Strategy Planning live session at the March 2020 Annual MAPS Conference.
The session speakers who provided these critical intellectual components of Building the Medical Affairs Strategic Plan are: Peter Piliero, MD, Vice President & Head, Medical Affairs Americas at GSK Consumer Healthcare; Eileen K Sawyer, PhD, Vice-President, Global Medical Affairs, UniQure; and, Anna Walz, CEO of MedEvoke.